WHITEHAWK THERAPEUTICS, INC. Investing Cash Flow
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Investing Cash Flow of $2.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$16.87M.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $19.43M, a 83.18% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $16.85M, a 28.27% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$91.63M, a 1901.91% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $11.89M, a 52.82% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $25.20M, a 69.71% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was $83.21M.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$132.89M, a 628.31% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.56M 10-Q · filed 2026-08-06 | $19.41M derived: sum of 3 quarters · filed 2026-08-06 | -$72.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $19.43M 10-Q · filed 2026-05-07 | $36.28M derived: sum of 2 quarters · filed 2026-05-07 | -$55.35M derived: sum of 3 quarters · filed 2026-05-07 | -$84.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$74.78M derived: sum of 2 quarters · filed 2026-03-12 | -$103.61M derived: sum of 3 quarters · filed 2026-08-06 | $11.89M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$91.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$120.45M derived: sum of 2 quarters · filed 2026-08-06 | -$4.96M 10-Q · filed 2025-11-06 | $8.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$28.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $86.67M 10-Q · filed 2026-08-06 | $99.81M derived: sum of 3 quarters · filed 2026-08-06 | $104.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $115.50M 10-Q · filed 2026-05-07 | $128.63M derived: sum of 2 quarters · filed 2026-05-07 | $133.72M derived: sum of 3 quarters · filed 2026-05-07 | $130.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $18.22M derived: sum of 2 quarters · filed 2026-03-12 | $14.65M derived: sum of 3 quarters · filed 2026-03-12 | $25.20M 10-K · filed 2026-03-12 |
| 2024-09-30 | $5.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.51M derived: sum of 2 quarters · filed 2025-11-06 | $12.07M 10-Q · filed 2025-11-06 | $15.72M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.98M 10-Q · filed 2025-08-07 | $10.63M derived: sum of 3 quarters · filed 2025-08-07 | $23.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $10.55M 10-Q · filed 2025-05-08 | $14.20M derived: sum of 2 quarters · filed 2025-05-08 | $26.87M derived: sum of 3 quarters · filed 2025-05-08 | $77.43M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $16.32M derived: sum of 2 quarters · filed 2025-03-28 | $66.88M derived: sum of 3 quarters · filed 2025-03-28 | $83.21M 10-K · filed 2025-03-28 |
| 2023-09-30 | $12.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $63.23M derived: sum of 2 quarters · filed 2024-11-06 | $79.56M 10-Q · filed 2024-11-06 | -$4.82M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $50.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $66.89M 10-Q · filed 2024-08-07 | -$17.49M derived: sum of 3 quarters · filed 2024-08-07 | -$65.73M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $16.33M 10-Q · filed 2024-05-08 | -$68.05M derived: sum of 2 quarters · filed 2024-05-08 | -$116.29M derived: sum of 3 quarters · filed 2024-05-08 | -$116.53M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$84.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$132.62M derived: sum of 2 quarters · filed 2024-03-13 | -$132.86M derived: sum of 3 quarters · filed 2024-03-13 | -$132.89M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$48.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$48.48M derived: sum of 2 quarters · filed 2023-11-08 | -$48.51M 10-Q · filed 2023-11-08 | -$48.55M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$264.00K 10-Q · filed 2023-08-09 | -$310.00K derived: sum of 3 quarters · filed 2023-08-09 | $25.05M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$23.00K 10-Q · filed 2023-05-10 | -$69.00K derived: sum of 2 quarters · filed 2023-05-10 | $25.29M derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $25.31M derived: sum of 2 quarters · filed 2023-03-29 | $25.15M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $25.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $25.20M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$157.00K 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$6.83K derived: sum of 2 quarters · filed 2021-03-11 | -$19.02K 10-K · filed 2021-03-11 | |
| 2020-09-30 | -$6.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$19.02K 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | -$12.20K 10-Q · filed 2021-08-11 | |||
| 2019-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$4.28K derived: sum of 2 quarters · filed 2021-03-11 | -$123.67K derived: sum of 3 quarters · filed 2021-03-11 | -$236.95K 10-K · filed 2021-03-11 |
| 2019-09-30 | -$4.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$123.67K derived: sum of 2 quarters · filed 2020-11-10 | -$236.95K 10-Q · filed 2020-11-10 | -$245.49K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$119.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$232.67K 10-Q · filed 2020-08-12 | -$241.20K derived: sum of 3 quarters · filed 2020-08-12 | -$262.09K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$113.28K 10-Q · filed 2020-05-07 | -$121.81K derived: sum of 2 quarters · filed 2020-05-07 | -$142.70K derived: sum of 3 quarters · filed 2020-05-07 | -$142.70K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$8.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$29.41K derived: sum of 2 quarters · filed 2020-03-16 | -$29.41K derived: sum of 3 quarters · filed 2020-03-16 | -$37.91K 10-K · filed 2020-03-16 |
| 2018-09-30 | -$20.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$20.88K derived: sum of 2 quarters · filed 2019-11-07 | -$29.38K 10-Q · filed 2019-11-07 | $18.27K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$8.50K 10-Q · filed 2019-08-08 | $39.15K derived: sum of 3 quarters · filed 2019-08-08 | $39.15K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$8.50K 10-Q · filed 2019-05-09 | $39.15K derived: sum of 2 quarters · filed 2019-05-09 | $39.15K derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $47.65K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $47.65K derived: sum of 2 quarters · filed 2019-03-07 | $41.10K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$6.55K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$6.55K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |